05:37 AM EDT, 08/15/2024 (MT Newswires) -- Anew Medical ( WENA ) said Thursday it secured a US patent covering an RNA splice variant of human Klotho gene "s-KL" for the treatment of cognitive and neurodegenerative diseases.

The patent follows similar patents issued in Europe, China and other Asian markets, according to the company.

The intellectual property portfolio provides the company with rights to develop and commercialize new therapies for neurodegenerative diseases, including Alzheimer's, amyotrophic lateral sclerosis, Parkinson's, and other age-related disorders, the company said.

Price: 0.9505, Change: -0.05, Percent Change: -4.95